Cargando…
Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence
A 26-year-old man highly suspected of having antiglomerular basement membrane (GBM) disease was treated with corticosteroid pulse therapy 9 days after initial infection-like symptoms with high procalcitonin value. The patient required hemodialysis the next day of the treatment due to oliguria. In ad...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660776/ https://www.ncbi.nlm.nih.gov/pubmed/29158928 http://dx.doi.org/10.1155/2017/7143649 |
_version_ | 1783274354792988672 |
---|---|
author | Fujigaki, Yoshihide Morimoto, Chikayuki Iino, Risa Taniguchi, Kei Kawamorita, Yosuke Asakawa, Shinichiro Toyoki, Daigo Miyano, Shinako Fujii, Wataru Ota, Tatsuru Shibata, Shigeru Uchida, Shunya |
author_facet | Fujigaki, Yoshihide Morimoto, Chikayuki Iino, Risa Taniguchi, Kei Kawamorita, Yosuke Asakawa, Shinichiro Toyoki, Daigo Miyano, Shinako Fujii, Wataru Ota, Tatsuru Shibata, Shigeru Uchida, Shunya |
author_sort | Fujigaki, Yoshihide |
collection | PubMed |
description | A 26-year-old man highly suspected of having antiglomerular basement membrane (GBM) disease was treated with corticosteroid pulse therapy 9 days after initial infection-like symptoms with high procalcitonin value. The patient required hemodialysis the next day of the treatment due to oliguria. In addition to corticosteroid therapy, plasmapheresis was introduced and the patient could discontinue hemodialysis 43 days after the treatment. Kidney biopsy after initiation of hemodialysis confirmed anti-GBM disease with 86.3% crescent formation. Physician should keep in mind that active anti-GBM disease shows even high procalcitonin value in the absence of infection. To pursue recovery of renal function, the challenge of the immediate and persistent treatment with high-dose corticosteroids plus plasmapheresis for highly suspected anti-GBM disease is vitally important despite the presence of reported predictors for dialysis-dependence including oliguria and requiring hemodialysis at presentation. |
format | Online Article Text |
id | pubmed-5660776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-56607762017-11-20 Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence Fujigaki, Yoshihide Morimoto, Chikayuki Iino, Risa Taniguchi, Kei Kawamorita, Yosuke Asakawa, Shinichiro Toyoki, Daigo Miyano, Shinako Fujii, Wataru Ota, Tatsuru Shibata, Shigeru Uchida, Shunya Case Rep Nephrol Case Report A 26-year-old man highly suspected of having antiglomerular basement membrane (GBM) disease was treated with corticosteroid pulse therapy 9 days after initial infection-like symptoms with high procalcitonin value. The patient required hemodialysis the next day of the treatment due to oliguria. In addition to corticosteroid therapy, plasmapheresis was introduced and the patient could discontinue hemodialysis 43 days after the treatment. Kidney biopsy after initiation of hemodialysis confirmed anti-GBM disease with 86.3% crescent formation. Physician should keep in mind that active anti-GBM disease shows even high procalcitonin value in the absence of infection. To pursue recovery of renal function, the challenge of the immediate and persistent treatment with high-dose corticosteroids plus plasmapheresis for highly suspected anti-GBM disease is vitally important despite the presence of reported predictors for dialysis-dependence including oliguria and requiring hemodialysis at presentation. Hindawi 2017 2017-10-11 /pmc/articles/PMC5660776/ /pubmed/29158928 http://dx.doi.org/10.1155/2017/7143649 Text en Copyright © 2017 Yoshihide Fujigaki et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Fujigaki, Yoshihide Morimoto, Chikayuki Iino, Risa Taniguchi, Kei Kawamorita, Yosuke Asakawa, Shinichiro Toyoki, Daigo Miyano, Shinako Fujii, Wataru Ota, Tatsuru Shibata, Shigeru Uchida, Shunya Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
title | Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
title_full | Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
title_fullStr | Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
title_full_unstemmed | Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
title_short | Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence |
title_sort | discontinuation of hemodialysis in a patient with anti-gbm disease by the treatment with corticosteroids and plasmapheresis despite several predictors for dialysis-dependence |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660776/ https://www.ncbi.nlm.nih.gov/pubmed/29158928 http://dx.doi.org/10.1155/2017/7143649 |
work_keys_str_mv | AT fujigakiyoshihide discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT morimotochikayuki discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT iinorisa discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT taniguchikei discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT kawamoritayosuke discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT asakawashinichiro discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT toyokidaigo discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT miyanoshinako discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT fujiiwataru discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT otatatsuru discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT shibatashigeru discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence AT uchidashunya discontinuationofhemodialysisinapatientwithantigbmdiseasebythetreatmentwithcorticosteroidsandplasmapheresisdespiteseveralpredictorsfordialysisdependence |